Response monitoring in children with phenylketonuria

Gabriel C Araujo1, Shawn E Christ, Robert D Steiner

  • 1Department of Psychology, Washington University, St.Louis, MO 63130, USA.

Neuropsychology
|February 13, 2009
PubMed

Insights

Children with phenylketonuria (PKU) show impaired response monitoring. This study found that children with PKU exhibit less posterror slowing, indicating a deficit in their ability to monitor and adjust their performance after making mistakes.

Area of Science:

  • Neuropsychology
  • Developmental Psychology
  • Metabolic Disorders

Background:

  • Phenylketonuria (PKU) disrupts phenylalanine metabolism, leading to dopamine deficiency and white matter abnormalities.
  • Neuropsychological studies link prefrontal dysfunction to executive ability deficits in individuals with PKU.
  • Executive functions, crucial for cognitive control, are often impaired in PKU.

Purpose of the Study:

  • To investigate response monitoring, a key executive ability, in children with PKU.
  • To measure posterror slowing as an indicator of response monitoring efficiency.
  • To compare response monitoring between early-treated children with PKU and typically developing controls.

Main Methods:

  • A go/no-go task was administered to assess reaction times.
  • Posterror reaction times were analyzed in 24 children with well-controlled, early-treated PKU.
  • Reaction times of 25 typically developing children served as controls.

Main Results:

  • Both control children and children with PKU demonstrated significant posterror slowing.
  • The magnitude of posterror slowing was significantly reduced in children with PKU compared to controls.
  • This suggests a deficiency in response monitoring in children with PKU.

Conclusions:

  • Children with PKU exhibit deficient response monitoring.
  • Impaired response monitoring may contribute to executive function deficits observed in PKU.
  • Early and well-controlled treatment may not fully normalize response monitoring abilities.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...